Evidence map›Paper›PMID 35570915›Full record

ArticleFrontiers in public health2022

Prostate Cancer Patterns and Trends in the Eastern Cape Province of South Africa; 1998-2017.

Thendo Michael Ramaliba, Nomfuneko Sithole, Akhona Ncinitwa, Nontuthuzelo I M Somdyala

Abstract read
In one paragraph

Article in Frontiers in public health, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Article
  3. Observational
  4. Review
  5. Article
  6. Review
  7. Observational
  8. The profile of Black South African men diagnosed with prostate cancer in the Free State, South Africa.South African family practice : official journal of the South African Academy of Family Practice/Primary Care · 2023
    Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Thendo Michael RamalibaBurden of Disease Research Unit, South African Medical Research Council, Cape Town, South Africa.
Nomfuneko SitholeBurden of Disease Research Unit, South African Medical Research Council, Cape Town, South Africa.
Akhona NcinitwaBurden of Disease Research Unit, South African Medical Research Council, Cape Town, South Africa.
Nontuthuzelo I M SomdyalaBurden of Disease Research Unit, South African Medical Research Council, Cape Town, South Africa.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Globally, prostate cancer is rated the second most common cancer and the sixth leading cause of death. In South Africa, it is ranked as leading cancer among men. This study describes prostate cancer patterns and trends in the rural Eastern Cape Province population. Methodology: Secondary data were used from which a sample of 723 prostate cancer (C61) patients was extracted from the database into STATA version 14.0 for descriptive analysis. A direct standardization method was used to estimate age-specific and age-standardized incidence rates. Keyfitz method was used to calculate the standard error and confidence interval, whereas the Joinpoint program the annual percentage change. Results: The mean age was 64 years, with a standard deviation of 9.9. Trends in prostate cancer incidence increased significantly ( Conclusion: As experienced globally and regionally, prostate cancer has become a public health concern in this population. Incidence variations across the surveillance area in the Eastern Cape were noted with hotspots.

Indexed as

Prostatic NeoplasmsDatabases, FactualHumansIncidenceMaleMiddle AgedRural PopulationSouth AfricaEastern Capeincidence ratemagisterial areaprostate cancerrural population

Identifiers

PMID35570915
PMCPMC9096153

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.